Cancer Survivors Need More Access to Equitable Care
The 2022-2024 edition of "Cancer Treatment & Survivorship Facts & Figures" is now available to help the public health community better met the unique needs of an expanding and diverse population of cancer survivors. The bottom line? The number of people living after a cancer diagnosis keeps rising, naturally due to population growth and aging, plus better treatment and early detection. And racial/ethnic disparities in cancer care persist.
For Your Best Life After Cancer—Eat Well & Be Physically Active
Updated ACS guidelines for diet and physical activity aim to help cancer survivors reduce their risk for the cancer's return and for dying from cancer.
More Black Women Die from Breast Cancer Than Any Other Cancer
New Cancer Facts & Figures for African American/Black People finds breast cancer now surpasses lung as the leading cause of cancer death in Black women.
Slideshow: COVID-19 Pandemic Affects the Cancer Continuum
ACS 2021 studies show how COVID-19 is affecting prevention efforts, expected cancer screening rates, treatment, quality-of-life, and research.
Risk of Dying from Cancer Continues to Drop at an Accelerated Pace
New 2022 cancer facts and figures show overall improvement, with new milestones for early detection of lung cancer, but with slowing progress for prostate and breast cancer.
Six Plan-ahead Tips to Eat Smarter This Holiday Season
Have a jolly, festive time at holiday parties this month while sticking to your healthy eating goals. Follow our tips to enjoy the season without having to pay for it later.
Get a Healthy Back-to-School Start
Put health on your back-to-school planning list this year. Vaccinations, nutritious lunches, and sleeping right are all part of the equation.
Impact Ratings Show Cancer Journal Continues to Outperform
The annual scientific and clinical Journal Impact Factors were released on June 30, and the American Cancer Society’s CA: A Cancer Journal for Clinicians outperformed. The CA impact factor climbed from 292.3 last year to a staggering 508.7 and remains the highest-rated oncology journal in the world.